urelumab

Home
Ligands
urelumab

Ligand id: 9311

Name: urelumab

Summary
Biological activity
Clinical data
References

Classification
Compound class	Antibody

International Nonproprietary Names
INN number	INN
9365	urelumab

Synonyms
BMS 663513
BMS-663513

Synonyms

BMS 663513

BMS-663513

Database Links
Specialist databases
IMGT/mAb-DB	373
Other databases
Search PubMed clinical trials	urelumab
Search PubMed titles	urelumab
Search PubMed titles/abstracts	urelumab

Comments
Urelumab (BMS-663513) is an investigational monoclonal antibody with agonist activity at the tumour necrosis factor (TNF) receptor, 4-1BB (TNFRSF9), being investigated for potential clinical immunostimulatory activity in the immuno-oncology setting [2-4]. Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequences for urelumab are identical matches for peptides claimed in patent WO2005035584, which leads to identification of clone 20H4-9-IgG4 [1].

Comments

Urelumab (BMS-663513) is an investigational monoclonal antibody with agonist activity at the tumour necrosis factor (TNF) receptor, 4-1BB (TNFRSF9), being investigated for potential clinical immunostimulatory activity in the immuno-oncology setting [2-4].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequences for urelumab are identical matches for peptides claimed in patent WO2005035584, which leads to identification of clone 20H4-9-IgG4 [1].